SCHEMBL4752791

SCHEMBL4752791

NC(=O)n1nc(N)c2s[c]nc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5578043 0.81
SCHEMBL3224786 0.55
SCHEMBL8776965 0.54
SCHEMBL23829118 0.47 PDPK1 (0.32)
Carbamic Acid SCHEMBL1149445 0.46
Carbamic Acid SCHEMBL6019094 0.45 CYP1A2 (0.55)
Carbamic Acid SCHEMBL21315591 0.45 CYP1A2 (0.55)
Carbamic Acid SCHEMBL63902 0.45 CYP1A2 (0.55)
Carbamic Acid SCHEMBL75781 0.42
Carbamic Acid SCHEMBL4456232 0.42 ACHE (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966222-A2 PYRAZOLOTHIAZOLE PROTEIN KINASE MODULATORS SGX Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
WO-2007059341-A2 PYRAZOLOTHIAZOLE PROTEIN KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-24 WO disclosed